GlassScriptPhysician profile
Jaime Lyn Dail
NPI 1073089249
$1,034.90
in general payments reported to CMS, 2019-2025
13 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $91.13 · 2023: $87.28 · 2024: $517 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $391.75 | 2021-2025 | Pico, Acticoat 4" X 4", Renasys Touch |
| Solventum Corporation | $144.54 | 2024 | V.A.C. Veraflo, 3m Cavilon, Tegaderm |
| Kerecis Limited | $138.18 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Molnlycke Health Care US, LLC | $87.28 | 2023 | Mepilex Border Sacrum, Mepilex Border Flex, Exufiber Ag+ |
| Lifenet Health | $84.25 | 2024 | Theragenesis Wound Matrix |
| Hartmann USA, INC. | $42.42 | 2024-2025 | Zetuvit Plus 10x10 P10 |
| Integra Lifesciences Corporation | $33.35 | 2024 | Tcc-Ez |
| Bioventus LLC | $24.92 | 2022 | |
| Cashflow Solutions, LLC | $20.38 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Organogenesis INC. | $19.53 | 2025 | Puraply Wound Matrix |
| Ovik Health, LLC | $18.08 | 2021 | |
| Mimedx Group, INC. | $15.14 | 2024 | |
| Kci USA, INC. | $15.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Dail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.